SCOPUS 정보 검색 플랫폼

Volumn 60, Issue 2, 2016, Pages 1013-1021

Towards rational dosing algorithms for vancomycin in neonates and infants based on population pharmacokinetic modeling

(9) Janssen, Esther J H a Välitalo, Pyry A J a Allegaert, Karel b De Cock, Roosmarijn F W a Simons, Sinno H P c Sherwin, Catherine M T d Mouton, Johan W c Van Den Anker, Johannes N c,e,f Knibbe, Catherijne A J a,g

a LEIDEN UNIVERSITY (Netherlands)

b UNIVERSITY HOSPITALS LEUVEN (Belgium)

c SOPHIA CHILDREN S HOSPITAL (Netherlands)

d UNIVERSITY OF UTAH SCHOOL OF MEDICINE (United States)

e CHILDREN'S NATIONAL MEDICAL CENTER (United States)

f UNIVERSITY CHILDREN S HOSPITAL (Switzerland)

g ST ANTONIUS HOSPITAL (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; VANCOMYCIN;

ALGORITHM; AREA UNDER THE CURVE; ARTICLE; BIRTH WEIGHT; CONCENTRATION AT STEADY-STATE; DRUG DOSE REGIMEN; GESTATIONAL AGE; HUMAN; INFANT; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; PRACTICE GUIDELINE; PREDICTION; PREMATURITY; PRIORITY JOURNAL; SIMULATION; STEADY STATE; COMPUTER SIMULATION; MICROBIAL SENSITIVITY TEST; REPRODUCIBILITY; THEORETICAL MODEL;

ALGORITHMS; AREA UNDER CURVE; COMPUTER SIMULATION; HUMANS; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; MODELS, THEORETICAL; REPRODUCIBILITY OF RESULTS; VANCOMYCIN;

EID: 84957900848 PISSN: 00664804 EISSN: 10986596 Source Type: Journal
DOI: 10.1128/AAC.01968-15 Document Type: Article

Times cited : (53)

References (68)

1
- 33747495601
- Off-label and unlicensed prescribing for newborns and children in different settings: A review of the literature and a consideration about drug safety
- Cuzzolin L, Atzei A, Fanos V. 2006. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 5:703-718. http://dx.doi.org/10.1517/14740338.5.5.703.
- (2006) Expert Opin Drug Saf , vol.5 , pp. 703-718
- Cuzzolin, L.¹ Atzei, A.² Fanos, V.³

2
- 79960185229
- Individualized dosing regimens in children based on population PKPD modelling: Are we ready for it?
- Knibbe CAJ, Danhof M. 2011. Individualized dosing regimens in children based on population PKPD modelling: are we ready for it? Int J Pharm 415:9-14. http://dx.doi.org/10.1016/j.ijpharm.2011.02.056.
- (2011) Int J Pharm , vol.415 , pp. 9-14
- Knibbe, C.A.J.¹ Danhof, M.²

3
- 79955596580
- The role of population PK-PD modelling in paediatric clinical research
- De Cock RFW, Piana C, Krekels EHJ, Danhof M, Allegaert K, Knibbe CAJ. 2011. The role of population PK-PD modelling in paediatric clinical research. Eur J Clin Pharmacol 67(Suppl 1):5-16. http://dx.doi.org/10.1007/s00228-009-0782-9.
- (2011) Eur J Clin Pharmacol , vol.67 , pp. 5-16
- De Cock, R.F.W.¹ Piana, C.² Krekels, E.H.J.³ Danhof, M.⁴ Allegaert, K.⁵ Knibbe, C.A.J.⁶

4
- 61649112659
- Tailor-made drug treatment for children: Creation of an infrastructure for data-sharing and population PK-PD modeling
- Ince I, de Wildt SN, Tibboel D, Danhof M, Knibbe CAJ. 2009. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling. Drug Discov Today 14:316-320. http://dx.doi.org/10.1016/j.drudis.2008.11.004.
- (2009) Drug Discov Today , vol.14 , pp. 316-320
- Ince, I.¹ De Wildt, S.N.² Tibboel, D.³ Danhof, M.⁴ Knibbe, C.A.J.⁵

5
- 84894024419
- Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling
- Admiraal R, van Kesteren C, Boelens JJ, Bredius RGM, Tibboel D, Knibbe CAJ. 2014. Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling. Arch Dis Child 99:267-272. http://dx.doi.org/10.1136/archdischild-2013-303721.
- (2014) Arch Dis Child , vol.99 , pp. 267-272
- Admiraal, R.¹ Van Kesteren, C.² Boelens, J.J.³ Bredius, R.G.M.⁴ Tibboel, D.⁵ Knibbe, C.A.J.⁶

6
- 84855910834
- Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance
- De Cock RF, Allegaert K, Schreuder MF, Sherwin CM, de Hoog M, van den Anker JN, Danhof M, Knibbe CA. 2012. Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance. Clin Pharmacokinet 51:105-117. http://dx.doi.org/10.2165/11595640-000000000-00000.
- (2012) Clin Pharmacokinet , vol.51 , pp. 105-117
- De Cock, R.F.¹ Allegaert, K.² Schreuder, M.F.³ Sherwin, C.M.⁴ De Hoog, M.⁵ Van Den Anker, J.N.⁶ Danhof, M.⁷ Knibbe, C.A.⁸

7
- 84903710721
- Evidence-based morphine dosing for postoperative neonates and infants
- Krekels EHJ, Tibboel D, de Wildt SN, Ceelie I, Dahan A, van Dijk M, Danhof M, Knibbe CAJ. 2014. Evidence-based morphine dosing for postoperative neonates and infants. Clin Pharmacokinet 53:553-563. http://dx.doi.org/10.1007/s40262-014-0135-4.
- (2014) Clin Pharmacokinet , vol.53 , pp. 553-563
- Krekels, E.H.J.¹ Tibboel, D.² De Wildt, S.N.³ Ceelie, I.⁴ Dahan, A.⁵ Van Dijk, M.⁶ Danhof, M.⁷ Knibbe, C.A.J.⁸

8
- 84866556540
- Predictive performance of a busulfan pharmacokinetic model in children and young adults
- Bartelink IH, van Kesteren C, Boelens JJ, Egberts TCG, Bierings MB, Cuvelier GDE, Wynn RF, Slatter MA, Chiesa R, Danhof M, Knibbe CAJ. 2012. Predictive performance of a busulfan pharmacokinetic model in children and young adults. Ther Drug Monit 34:574-583. http://dx.doi.org/10.1097/FTD.0b013e31826051bb.
- (2012) Ther Drug Monit , vol.34 , pp. 574-583
- Bartelink, I.H.¹ Van Kesteren, C.² Boelens, J.J.³ Egberts, T.C.G.⁴ Bierings, M.B.⁵ Cuvelier, G.D.E.⁶ Wynn, R.F.⁷ Slatter, M.A.⁸ Chiesa, R.⁹ Danhof, M.¹⁰ Knibbe, C.A.J.¹¹

9
- 84936936980
- Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates
- Valitalo PAJ, van den Anker JN, Allegaert K, de Cock RFW, de Hoog M, Simons SHP, Mouton JW, Knibbe CAJ. 2015. Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates. J Antimicrob Chemother 70:2074-2077. http://dx.doi.org/10.1093/jac/dkv052.
- (2015) J Antimicrob Chemother , vol.70 , pp. 2074-2077
- Valitalo, P.A.J.¹ Van Den Anker, J.N.² Allegaert, K.³ De Cock, R.F.W.⁴ De Hoog, M.⁵ Simons, S.H.P.⁶ Mouton, J.W.⁷ Knibbe, C.A.J.⁸

10
- 77952118055
- EuroCept BV, Ankeveen, the Netherlands
- EuroCept BV. 2010. Summary of product characteristics: Vancocin. EuroCept BV, Ankeveen, the Netherlands.
- (2010) Summary of Product Characteristics: Vancocin
- EuroCept BV¹

11
- 2642532792
- Vancomycin: Pharmacokinetics and administration regimens in neonates
- de Hoog M, Mouton JW, van den Anker JN. 2004. Vancomycin: pharmacokinetics and administration regimens in neonates. Clin Pharmacokinet 43:417-440. http://dx.doi.org/10.2165/00003088-200443070-00001.
- (2004) Clin Pharmacokinet , vol.43 , pp. 417-440
- De Hoog, M.¹ Mouton, J.W.² Van Den Anker, J.N.³

12
- 33747754782
- Coagulase-negative staphylococcal infections in the neonate and child: An update
- Venkatesh MP, Placencia F, Weisman LE. 2006. Coagulase-negative staphylococcal infections in the neonate and child: an update. Semin Pediatr Infect Dis 17:120-127. http://dx.doi.org/10.1053/j.spid.2006.06.005.
- (2006) Semin Pediatr Infect Dis , vol.17 , pp. 120-127
- Venkatesh, M.P.¹ Placencia, F.² Weisman, L.E.³

13
- 33846081133
- Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: Daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model
- Smirnova MV, Lubenko IY, Portnoy YA, Zinner SH, Firsov AA. 2007. Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model. Int J Antimicrob Agents 29:165-169. http://dx.doi.org/10.1016/j.ijantimicag.2006.09.011.
- (2007) Int J Antimicrob Agents , vol.29 , pp. 165-169
- Smirnova, M.V.¹ Lubenko, I.Y.² Portnoy, Y.A.³ Zinner, S.H.⁴ Firsov, A.A.⁵

14
- 29244442296
- The pharmacokinetic and pharmacodynamic properties of vancomycin
- Rybak MJ. 2006. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis 42:S35-9. http://dx.doi.org/10.1086/491712.
- (2006) Clin Infect Dis , vol.42 , pp. S35-S39
- Rybak, M.J.¹

15
- 0347694556
- Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid
- Craig WA. 2003. Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am 17:479-501. http://dx.doi.org/10.1016/S0891-5520(03)00065-5.
- (2003) Infect Dis Clin North Am , vol.17 , pp. 479-501
- Craig, W.A.¹

16
- 7444254040
- Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
- Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ. 2004. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 43:925-942. http://dx.doi.org/10.2165/00003088-200443130-00005.
- (2004) Clin Pharmacokinet , vol.43 , pp. 925-942
- Moise-Broder, P.A.¹ Forrest, A.² Birmingham, M.C.³ Schentag, J.J.⁴

17
- 62449183879
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
- Rybak M, Lomaestro B, Rotschafer JC, Moellering R, Craig W, Billeter M, Dalovisio JR, Levine DP. 2009. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 66:82-98. http://dx.doi.org/10.2146/ajhp080434.
- (2009) Am J Health Syst Pharm , vol.66 , pp. 82-98
- Rybak, M.¹ Lomaestro, B.² Rotschafer, J.C.³ Moellering, R.⁴ Craig, W.⁵ Billeter, M.⁶ Dalovisio, J.R.⁷ Levine, D.P.⁸

18
- 84911471790
- Vancomycin pharmacokinetic models: Informing the clinical management of drug-resistant bacterial infections
- Stockmann C, Roberts JK, Yu T, Constance JE, Knibbe CA, Spigarelli MG, Sherwin CM. 2014. Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections. Expert Rev Anti Infect Ther 12:1371-1388. http://dx.doi.org/10.1586/14787210.2014.966081.
- (2014) Expert Rev Anti Infect Ther , vol.12 , pp. 1371-1388
- Stockmann, C.¹ Roberts, J.K.² Yu, T.³ Constance, J.E.⁴ Knibbe, C.A.⁵ Spigarelli, M.G.⁶ Sherwin, C.M.⁷

19
- 84908302460
- Association between vancomycin trough concentration and area under the concentration-time curve in neonates
- Frymoyer A, Hersh AL, El-Komy MH, Gaskari S, Su F, Drover DR, Van Meurs K. 2014. Association between vancomycin trough concentration and area under the concentration-time curve in neonates. Antimicrob Agents Chemother 58:6454-6461. http://dx.doi.org/10.1128/AAC.03620-14.
- (2014) Antimicrob Agents Chemother , vol.58 , pp. 6454-6461
- Frymoyer, A.¹ Hersh, A.L.² El-Komy, M.H.³ Gaskari, S.⁴ Su, F.⁵ Drover, D.R.⁶ Van Meurs, K.⁷

20
- 84876295339
- Improved vancomycin dosing in children using area under the curve exposure
- Le J, Bradley JS, Murray W, Romanowski GL, Tran TT, Nguyen N, Cho S, Natale S, Bui I, Tran TM, Capparelli EV. 2013. Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J 32:e155-63. http://dx.doi.org/10.1097/INF.0b013e318286378e.
- (2013) Pediatr Infect Dis J , vol.32 , pp. e155-e163
- Le, J.¹ Bradley, J.S.² Murray, W.³ Romanowski, G.L.⁴ Tran, T.T.⁵ Nguyen, N.⁶ Cho, S.⁷ Natale, S.⁸ Bui, I.⁹ Tran, T.M.¹⁰ Capparelli, E.V.¹¹

21
- 84891836161
- Desired vancomycin trough serum concentration for treating invasive methicillin-resistant staphylococcal infections
- Frymoyer A, Guglielmo BJ, Hersh AL. 2013. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant staphylococcal infections. Pediatr Infect Dis J 32:1077-1079. http://dx.doi.org/10.1097/INF.0b013e318299f75c.
- (2013) Pediatr Infect Dis J , vol.32 , pp. 1077-1079
- Frymoyer, A.¹ Guglielmo, B.J.² Hersh, A.L.³

22
- 84895481895
- A neonatal amikacin covariate model can be used to predict ontogeny of other drugs eliminated through glomerular filtration in neonates
- De Cock RFW, Allegaert K, Sherwin CMT, Nielsen EI, de Hoog M, van den Anker JN, Danhof M, Knibbe CAJ. 2014. A neonatal amikacin covariate model can be used to predict ontogeny of other drugs eliminated through glomerular filtration in neonates. Pharm Res 31:754-767. http://dx.doi.org/10.1007/s11095-013-1197-y.
- (2014) Pharm Res , vol.31 , pp. 754-767
- De Cock, R.F.W.¹ Allegaert, K.² Sherwin, C.M.T.³ Nielsen, E.I.⁴ De Hoog, M.⁵ Van Den Anker, J.N.⁶ Danhof, M.⁷ Knibbe, C.A.J.⁸

23
- 84931098560
- Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: Towards a semi-physiological function for maturation in glomerular filtration
- De Cock RFW, Allegaert K, Brussee JM, Sherwin CMT, Mulla H, de Hoog M, van den Anker JN, Danhof M, Knibbe CAJ. 2014. Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration. Pharm Res 31:2643-2654. http://dx.doi.org/10.1007/s11095-014-1361-z.
- (2014) Pharm Res , vol.31 , pp. 2643-2654
- De Cock, R.F.W.¹ Allegaert, K.² Brussee, J.M.³ Sherwin, C.M.T.⁴ Mulla, H.⁵ De Hoog, M.⁶ Van Den Anker, J.N.⁷ Danhof, M.⁸ Knibbe, C.A.J.⁹

24
- 33845453628
- Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance
- Anderson BJ, Allegaert K, Van den Anker JN, Cossey V, Holford NHG. 2007. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. Br J Clin Pharmacol 63:75-84. http://dx.doi.org/10.1111/j.1365-2125.2006.02725.x.
- (2007) Br J Clin Pharmacol , vol.63 , pp. 75-84
- Anderson, B.J.¹ Allegaert, K.² Van Den Anker, J.N.³ Cossey, V.⁴ Holford, N.H.G.⁵

25
- 0034867933
- The influences of renal function and maturation on vancomycin elimination in newborns and infants
- Capparelli EV, Lane JR, Romanowski GL, McFeely EJ, Murray W, Sousa P, Kildoo C, Connor JD. 2001. The influences of renal function and maturation on vancomycin elimination in newborns and infants. J Clin Pharmacol 41:927-934. http://dx.doi.org/10.1177/00912700122010898.
- (2001) J Clin Pharmacol , vol.41 , pp. 927-934
- Capparelli, E.V.¹ Lane, J.R.² Romanowski, G.L.³ McFeely, E.J.⁴ Murray, W.⁵ Sousa, P.⁶ Kildoo, C.⁷ Connor, J.D.⁸

26
- 81155127325
- Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children
- Giachetto GA, Telechea HM, Speranza N, Oyarzun M, Nanni L, Menchaca A. 2011. Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children. Pediatr Crit Care Med 12:e250-4. http://dx.doi.org/10.1097/PCC.0b013e3181fe4047.
- (2011) Pediatr Crit Care Med , vol.12 , pp. e250-e254
- Giachetto, G.A.¹ Telechea, H.M.² Speranza, N.³ Oyarzun, M.⁴ Nanni, L.⁵ Menchaca, A.⁶

27
- 0032694696
- Pharmacokinetics and dose requirements of vancomycin in neonates
- Grimsley C, Thomson AH. 1999. Pharmacokinetics and dose requirements of vancomycin in neonates. Arch Dis Child Fetal Neonatal Ed 81:F221-7. http://dx.doi.org/10.1136/fn.81.3.F221.
- (1999) Arch Dis Child Fetal Neonatal Ed , vol.81 , pp. F221-F227
- Grimsley, C.¹ Thomson, A.H.²

28
- 0034055873
- Vancomycin population pharmacokinetics in neonates
- de Hoog M, Schoemaker RC, Mouton JW, van den Anker JN. 2000. Vancomycin population pharmacokinetics in neonates. Clin Pharmacol Ther 67:360-367. http://dx.doi.org/10.1067/mcp.2000.105353.
- (2000) Clin Pharmacol Ther , vol.67 , pp. 360-367
- De Hoog, M.¹ Schoemaker, R.C.² Mouton, J.W.³ Van Den Anker, J.N.⁴

29
- 1642502349
- Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates
- Kimura T, Sunakawa K, Matsuura N, Kubo H, Shimada S, Yago K. 2004. Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates. Antimicrob Agents Chemother 48:1159-1167. http://dx.doi.org/10.1128/AAC.48.4.1159-1167.2004.
- (2004) Antimicrob Agents Chemother , vol.48 , pp. 1159-1167
- Kimura, T.¹ Sunakawa, K.² Matsuura, N.³ Kubo, H.⁴ Shimada, S.⁵ Yago, K.⁶

30
- 78649243161
- Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline
- Marqués-Miñana M-R, Saadeddin A, Peris J-E. 2010. Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline. Br J Clin Pharmacol 70:713-720. http://dx.doi.org/10.1111/j.1365-2125.2010.03736.x.
- (2010) Br J Clin Pharmacol , vol.70 , pp. 713-720
- Marqués-Miñana, M.-R.¹ Saadeddin, A.² Peris, J.-E.³

31
- 80051784208
- Vancomycin prescription in neonates and young infants: Toward a simplified dosage
- Oudin C, Vialet R, Boulamery A, Martin C, Simon N. 2011. Vancomycin prescription in neonates and young infants: toward a simplified dosage. Arch Dis Child Fetal Neonatal Ed 96:F365-70. http://dx.doi.org/10.1136/adc.2010.196402.
- (2011) Arch Dis Child Fetal Neonatal Ed , vol.96 , pp. F365-F370
- Oudin, C.¹ Vialet, R.² Boulamery, A.³ Martin, C.⁴ Simon, N.⁵

32
- 0027936316
- Population pharmacokinetics of vancomycin in neonates
- Seay RE, Brundage RC, Jensen PD, Schilling CG, Edgren BE. 1994. Population pharmacokinetics of vancomycin in neonates. Clin Pharmacol Ther 56:169-175. http://dx.doi.org/10.1038/clpt.1994.120.
- (1994) Clin Pharmacol Ther , vol.56 , pp. 169-175
- Seay, R.E.¹ Brundage, R.C.² Jensen, P.D.³ Schilling, C.G.⁴ Edgren, B.E.⁵

33
- 0031756964
- Population pharmacokinetics of vancomycin in Japanese pediatric patients
- Yasuhara M, Iga T, Zenda H, Okumura K, Oguma T, Yano Y, Hori R. 1998. Population pharmacokinetics of vancomycin in Japanese pediatric patients. Ther Drug Monit 20:612-618. http://dx.doi.org/10.1097/00007691-199812000-00005.
- (1998) Ther Drug Monit , vol.20 , pp. 612-618
- Yasuhara, M.¹ Iga, T.² Zenda, H.³ Okumura, K.⁴ Oguma, T.⁵ Yano, Y.⁶ Hori, R.⁷

34
- 84877631293
- Vancomycin continuous infusion in neonates: Dosing optimisation and therapeutic drug monitoring
- Zhao W, Lopez E, Biran V, Durrmeyer X, Fakhoury M, Jacqz-Aigrain E. 2013. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring. Arch Dis Child 98:449-453. http://dx.doi.org/10.1136/archdischild-2012-302765.
- (2013) Arch Dis Child , vol.98 , pp. 449-453
- Zhao, W.¹ Lopez, E.² Biran, V.³ Durrmeyer, X.⁴ Fakhoury, M.⁵ Jacqz-Aigrain, E.⁶

35
- 84901260278
- Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease
- Zhao W, Zhang D, Fakhoury M, Fahd M, Duquesne F, Storme T, Baruchel A, Jacqz-Aigrain E. 2014. Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease. Antimicrob Agents Chemother 58:3191-3199. http://dx.doi.org/10.1128/AAC.02564-13.
- (2014) Antimicrob Agents Chemother , vol.58 , pp. 3191-3199
- Zhao, W.¹ Zhang, D.² Fakhoury, M.³ Fahd, M.⁴ Duquesne, F.⁵ Storme, T.⁶ Baruchel, A.⁷ Jacqz-Aigrain, E.⁸

36
- 84890478559
- Amikacin maturation model as a marker of renal maturation to predict glomerular filtration rate and vancomycin clearance in neonates
- Zhao W, Biran V, Jacqz-Aigrain E. 2013. Amikacin maturation model as a marker of renal maturation to predict glomerular filtration rate and vancomycin clearance in neonates. Clin Pharmacokinet 52:1127-1134. http://dx.doi.org/10.1007/s40262-013-0101-6.
- (2013) Clin Pharmacokinet , vol.52 , pp. 1127-1134
- Zhao, W.¹ Biran, V.² Jacqz-Aigrain, E.³

37
- 84898476797
- Nederlands Kenniscentrum voor Farmacotherpie bij Kinderen, Rotterdam, the Netherlands
- Nederlands Kenniscentrum voor Farmacotherpie bij Kinderen. 2013. Kinderformularium. Nederlands Kenniscentrum voor Farmacotherpie bij Kinderen, Rotterdam, the Netherlands.
- (2013) Kinderformularium
- Nederlands Kenniscentrum voor Farmacotherpie bij Kinderen¹

38
- 78651484729
- BMJ Group, London, United Kingdom
- Paediatric Formulary Committee. 2009. British national formulary for children. BMJ Group, London, United Kingdom.
- (2009) British National Formulary for Children

39
- 79951821210
- Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: Executive summary
- Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF. 2011. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52:285-292. http://dx.doi.org/10.1093/cid/cir034.
- (2011) Clin Infect Dis , vol.52 , pp. 285-292
- Liu, C.¹ Bayer, A.² Cosgrove, S.E.³ Daum, R.S.⁴ Fridkin, S.K.⁵ Gorwitz, R.J.⁶ Kaplan, S.L.⁷ Karchmer, A.W.⁸ Levine, D.P.⁹ Murray, B.E.¹⁰ J Rybak, M.¹¹ Talan, D.A.¹² Chambers, H.F.¹³

40
- 84880269403
- 24th ed. PDR Network, Montvale, NJ
- Young TE, Mangum B, Thomson Reuters Clinical Editorial Staff. 2011. NeoFax, 24th ed. PDR Network, Montvale, NJ.
- (2011) NeoFax
- Young, T.E.¹ Mangum, B.²

41
- 84884086762
- 6th ed. BMJ Group, Chichester, United Kingdom
- Hey E, Northern Neonatal Network. 2011. Neonatal formulary 6; drug use in pregnancy and the first year of life, 6th ed. BMJ Group, Chichester, United Kingdom.
- (2011) Neonatal Formulary 6; Drug Use in Pregnancy and the First Year of Life
- Northern Neonatal Network¹ Hey, E.²

42
- 84913590311
- Prospective validation of neonatal vancomycin dosing regimens is urgently needed
- Vandendriessche A, Allegaert K, Cossey V, Naulaers G, Saegeman V, Smits A. 2014. Prospective validation of neonatal vancomycin dosing regimens is urgently needed. Curr Ther Res Clin Exp 76:51-57. http://dx.doi.org/10.1016/j.curtheres.2014.06.001.
- (2014) Curr Ther Res Clin Exp , vol.76 , pp. 51-57
- Vandendriessche, A.¹ Allegaert, K.² Cossey, V.³ Naulaers, G.⁴ Saegeman, V.⁵ Smits, A.⁶

43
- 79957606863
- Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients
- Eiland LS, English TM, Eiland EH. 2011. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients. Ann Pharmacother 45:582-589. http://dx.doi.org/10.1345/aph.1P588.
- (2011) Ann Pharmacother , vol.45 , pp. 582-589
- Eiland, L.S.¹ English, T.M.² Eiland, E.H.³

44
- 84879233141
- An evaluation of initial vancomycin dosing in infants, children, and adolescents
- Broome, L., So T-Y. 2011. An evaluation of initial vancomycin dosing in infants, children, and adolescents. Int J Pediatr 2011:470364. http://dx.doi.org/10.1155/2011/470364.
- (2011) Int J Pediatr , vol.2011
- Broome, L.¹ So, T.-Y.²

45
- 80052188407
- Impact of a hospital-wide increase in empiric pediatric vancomycin dosing on initial trough concentrations
- Frymoyer A, Guglielmo BJ, Wilson SD, Scarpace SB, Benet LZ, Hersh AL. 2011. Impact of a hospital-wide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Pharmacotherapy 31:871-876. http://dx.doi.org/10.1592/phco.31.9.871.
- (2011) Pharmacotherapy , vol.31 , pp. 871-876
- Frymoyer, A.¹ Guglielmo, B.J.² Wilson, S.D.³ Scarpace, S.B.⁴ Benet, L.Z.⁵ Hersh, A.L.⁶

46
- 84869753374
- Evaluation of a pediatric continuous-infusion vancomycin therapy guideline
- McKamy S, Chen T, Lee M, Ambrose PJ. 2012. Evaluation of a pediatric continuous-infusion vancomycin therapy guideline. Am J Health Syst Pharm 69:2066-2071. http://dx.doi.org/10.2146/ajhp120072.
- (2012) Am J Health Syst Pharm , vol.69 , pp. 2066-2071
- McKamy, S.¹ Chen, T.² Lee, M.³ Ambrose, P.J.⁴

47
- 0031829156
- Constant rate infusion of vancomycin in premature neonates: A new dosage schedule
- Pawlotsky F, Thomas A, Kergueris MF, Debillon T, Roze JC. 1998. Constant rate infusion of vancomycin in premature neonates: a new dosage schedule. Br J Clin Pharmacol 46:163-167.
- (1998) Br J Clin Pharmacol , vol.46 , pp. 163-167
- Pawlotsky, F.¹ Thomas, A.² Kergueris, M.F.³ Debillon, T.⁴ Roze, J.C.⁵

48
- 84877588616
- Continuous infusion of vancomycin in neonates
- Patel AD, Anand D, Lucas C, Thomson AH. 2013. Continuous infusion of vancomycin in neonates. Arch Dis Child 98:478-479. http://dx.doi.org/10.1136/archdischild-2012-303197.
- (2013) Arch Dis Child , vol.98 , pp. 478-479
- Patel, A.D.¹ Anand, D.² Lucas, C.³ Thomson, A.H.⁴

49
- 55349123652
- Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: A new dosage schedule
- Plan O, Cambonie G, Barbotte E, Meyer P, Devine C, Milesi C, Pidoux O, Badr M, Picaud JC. 2008. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule. Arch Dis Child Fetal Neonatal Ed 93:F418-21. http://dx.doi.org/10.1136/adc.2007.128280.
- (2008) Arch Dis Child Fetal Neonatal Ed , vol.93 , pp. F418-F421
- Plan, O.¹ Cambonie, G.² Barbotte, E.³ Meyer, P.⁴ Devine, C.⁵ Milesi, C.⁶ Pidoux, O.⁷ Badr, M.⁸ Picaud, J.C.⁹

50
- 2942744625
- Perl-speaks-NONMEM (PsN): A Perl module for NONMEM related programming
- Lindbom L, Ribbing J, Jonsson EN. 2004. Perl-speaks-NONMEM (PsN): a Perl module for NONMEM related programming. Comput Methods Programs Biomed 75:85-94. http://dx.doi.org/10.1016/j.cmpb.2003.11.003.
- (2004) Comput Methods Programs Biomed , vol.75 , pp. 85-94
- Lindbom, L.¹ Ribbing, J.² Jonsson, E.N.³

51
- 34447513694
- Renal drug clearance in preterm neonates: Relation to prenatal growth
- Allegaert K, Anderson BJ, van den Anker JN, Vanhaesebrouck S, de Zegher F. 2007. Renal drug clearance in preterm neonates: relation to prenatal growth. Ther Drug Monit 29:284-291. http://dx.doi.org/10.1097/FTD.0b013e31806db3f5.
- (2007) Ther Drug Monit , vol.29 , pp. 284-291
- Allegaert, K.¹ Anderson, B.J.² Van Den Anker, J.N.³ Vanhaesebrouck, S.⁴ De Zegher, F.⁵

52
- 40949086000
- Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The NPDE add-on package for R
- Comets E, Brendel K, Mentré F. 2008. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the NPDE add-on package for R. Comput Methods Programs Biomed 90:154-166. http://dx.doi.org/10.1016/j.cmpb.2007.12.002.
- (2008) Comput Methods Programs Biomed , vol.90 , pp. 154-166
- Comets, E.¹ Brendel, K.² Mentré, F.³

53
- 33750581706
- Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide
- Brendel K, Comets E, Laffont C, Laveille C, Mentré F. 2006. Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide. Pharm Res 23:2036-2049. http://dx.doi.org/10.1007/s11095-006-9067-5.
- (2006) Pharm Res , vol.23 , pp. 2036-2049
- Brendel, K.¹ Comets, E.² Laffont, C.³ Laveille, C.⁴ Mentré, F.⁵

54
- 0033958126
- A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population
- Lamarre P, Lebel D, Ducharme MP. 2000. A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population. Antimicrob Agents Chemother 44:278-282. http://dx.doi.org/10.1128/AAC.44.2.278-282.2000.
- (2000) Antimicrob Agents Chemother , vol.44 , pp. 278-282
- Lamarre, P.¹ Lebel, D.² Ducharme, M.P.³

55
- 84895521987
- Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation
- Lim H-S, Chong YP, Noh Y-H, Jung J-A, Kim YS. 2014. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation. J Clin Pharm Ther 39:196-203. http://dx.doi.org/10.1111/jcpt.12123.
- (2014) J Clin Pharm Ther , vol.39 , pp. 196-203
- Lim, H.-S.¹ Chong, Y.P.² Noh, Y.-H.³ Jung, J.-A.⁴ Kim, Y.S.⁵

56
- 84875069843
- External evaluation of population pharmacokinetic models of vancomycin in neonates: The transferability of published models to different clinical settings
- Zhao W, Kaguelidou F, Biran V, Zhang D, Allegaert K, Capparelli EV, Holford N, Kimura T, Lo Y-L, Peris J-E, Thomson A, van den Anker JN, Fakhoury M, Jacqz-Aigrain E. 2013. External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings. Br J Clin Pharmacol 75:1068-1080. http://dx.doi.org/10.1111/j.1365-2125.2012.04406.x.
- (2013) Br J Clin Pharmacol , vol.75 , pp. 1068-1080
- Zhao, W.¹ Kaguelidou, F.² Biran, V.³ Zhang, D.⁴ Allegaert, K.⁵ Capparelli, E.V.⁶ Holford, N.⁷ Kimura, T.⁸ Lo, Y.-L.⁹ Peris, J.-E.¹⁰ Thomson, A.¹¹ Van Den Anker, J.N.¹² Fakhoury, M.¹³ Jacqz-Aigrain, E.¹⁴

57
- 77952659134
- Population pharmacokinetics of vancomycin in premature Malaysian neonates: Identification of predictors for dosing determination
- Lo Y-L, van Hasselt JGC, Heng S-C, Lim C-T, Lee T-C, Charles BG. 2010. Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination. Antimicrob Agents Chemother 54:2626-2632. http://dx.doi.org/10.1128/AAC.01370-09.
- (2010) Antimicrob Agents Chemother , vol.54 , pp. 2626-2632
- Lo, Y.-L.¹ Van Hasselt, J.G.C.² Heng, S.-C.³ Lim, C.-T.⁴ Lee, T.-C.⁵ Charles, B.G.⁶

58
- 77954471736
- Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation
- Revilla N, Martín-Suárez A, Pérez MP, González FM, Fernández de Gatta MDM. 2010. Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation. Br J Clin Pharmacol 70:201-212. http://dx.doi.org/10.1111/j.1365-2125.2010.03679.x.
- (2010) Br J Clin Pharmacol , vol.70 , pp. 201-212
- Revilla, N.¹ Martín-Suárez, A.² Pérez, M.P.³ González, F.M.⁴ Fernández De Gatta, M.D.M.⁵

59
- 0023280085
- Vancomycin pharmacokinetics and dose recommendations for preterm infants
- James A, Koren G, Milliken J, Soldin S, Prober C. 1987. Vancomycin pharmacokinetics and dose recommendations for preterm infants. Antimicrob Agents Chemother 31:52-54. http://dx.doi.org/10.1128/AAC.31.1.52.
- (1987) Antimicrob Agents Chemother , vol.31 , pp. 52-54
- James, A.¹ Koren, G.² Milliken, J.³ Soldin, S.⁴ Prober, C.⁵

60
- 67649543995
- Current recommended dosing of vancomycin for children with invasive methicillinresistant Staphylococcus aureus infections is inadequate
- Frymoyer A, Hersh AL, Benet LZ, Guglielmo BJ. 2009. Current recommended dosing of vancomycin for children with invasive methicillinresistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J 28:398-402. http://dx.doi.org/10.1097/INF.0b013e3181906e40.
- (2009) Pediatr Infect Dis J , vol.28 , pp. 398-402
- Frymoyer, A.¹ Hersh, A.L.² Benet, L.Z.³ Guglielmo, B.J.⁴

61
- 84886952935
- A randomized controlled trial of a vancomycin loading dose in children
- Demirjian A, Finkelstein Y, Nava-Ocampo A, Arnold A, Jones S, Monuteaux M, Sandora TJ, Patterson A, Harper MB. 2013. A randomized controlled trial of a vancomycin loading dose in children. PediatrInfectDisJ32:1217-1223.http://dx.doi.org/10.1097/INF.0b013e3182a26774.
- (2013) PediatrInfectDisJ , vol.32 , pp. 1217-1223
- Demirjian, A.¹ Finkelstein, Y.² Nava-Ocampo, A.³ Arnold, A.⁴ Jones, S.⁵ Monuteaux, M.⁶ Sandora, T.J.⁷ Patterson, A.⁸ Harper, M.B.⁹

62
- 77951899851
- Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: A Monte Carlo simulation
- Frymoyer A, Hersh AL, Coralic Z, Benet LZ, Joseph Guglielmo B. 2010. Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation. Clin Ther 32:534-542. http://dx.doi.org/10.1016/j.clinthera.2010.03.005.
- (2010) Clin Ther , vol.32 , pp. 534-542
- Frymoyer, A.¹ Hersh, A.L.² Coralic, Z.³ Benet, L.Z.⁴ Joseph Guglielmo, B.⁵

63
- 84919608313
- A randomized trial of loading vancomycin in the emergency department
- Rosini JM, Laughner J, Levine BJ, Papas MA, Reinhardt JF, Jasani NB. 2015. A randomized trial of loading vancomycin in the emergency department. Ann Pharmacother 49:6-13. http://dx.doi.org/10.1177/1060028014556813.
- (2015) Ann Pharmacother , vol.49 , pp. 6-13
- Rosini, J.M.¹ Laughner, J.² Levine, B.J.³ Papas, M.A.⁴ Reinhardt, J.F.⁵ Jasani, N.B.⁶

64
- 84859170733
- Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: Systematic review and meta-analysis
- Cataldo MA, Tacconelli E, Grilli E, Pea F, Petrosillo N. 2012. Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother 67:17-24. http://dx.doi.org/10.1093/jac/dkr442.
- (2012) J Antimicrob Chemother , vol.67 , pp. 17-24
- Cataldo, M.A.¹ Tacconelli, E.² Grilli, E.³ Pea, F.⁴ Petrosillo, N.⁵

65
- 0036033066
- Ontogeny of hepatic and renal systemic clearance pathways in infants: Part II
- Alcorn J, McNamara PJ. 2002. Ontogeny of hepatic and renal systemic clearance pathways in infants: part II. Clin Pharmacokinet 41:1077-1094. http://dx.doi.org/10.2165/00003088-200241130-00005.
- (2002) Clin Pharmacokinet , vol.41 , pp. 1077-1094
- Alcorn, J.¹ McNamara, P.J.²

66
- 0141857724
- Developmental pharmacology - Drug disposition, action, and therapy in infants and children
- Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. 2003. Developmental pharmacology - drug disposition, action, and therapy in infants and children. N Engl J Med 349:1157-1167. http://dx.doi.org/10.1056/NEJMra035092.
- (2003) N Engl J Med , vol.349 , pp. 1157-1167
- Kearns, G.L.¹ Abdel-Rahman, S.M.² Alander, S.W.³ Blowey, D.L.⁴ Leeder, J.S.⁵ Kauffman, R.E.⁶

67
- 59849122627
- Human renal function maturation: A quantitative description using weight and postmenstrual age
- Rhodin MM, Anderson BJ, Peters AM, Coulthard MG, Wilkins B, Cole M, Chatelut E, Grubb A, Veal GJ, Keir MJ, Holford NHG. 2009. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol 24:67-76. http://dx.doi.org/10.1007/s00467-008-0997-5.
- (2009) Pediatr Nephrol , vol.24 , pp. 67-76
- Rhodin, M.M.¹ Anderson, B.J.² Peters, A.M.³ Coulthard, M.G.⁴ Wilkins, B.⁵ Cole, M.⁶ Chatelut, E.⁷ Grubb, A.⁸ Veal, G.J.⁹ Keir, M.J.¹⁰ Holford, N.H.G.¹¹

68
- 30944434484
- Ontogeny of drug elimination by the human kidney
- Chen N, Aleksa K, Woodland C, Rieder M, Koren G. 2006. Ontogeny of drug elimination by the human kidney. Pediatr Nephrol 21:160-168. http://dx.doi.org/10.1007/s00467-005-2105-4.
- (2006) Pediatr Nephrol , vol.21 , pp. 160-168
- Chen, N.¹ Aleksa, K.² Woodland, C.³ Rieder, M.⁴ Koren, G.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.